XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Securities available for sale, amortized cost $ 2,575,393 $ 2,526,644
Securities held to maturity, fair value $ 2,179,910 [1] $ 2,156,694 [2]
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, outstanding (in shares) 155,947,503 158,346,529
Common stock, issued (in shares) 156,135,165 158,557,735
Class B Nonvoting    
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, outstanding (in shares) 477,321  
Common stock, issued (in shares) 477,321 477,321
Nonvoting Common Stock    
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, issued (in shares) 9,790,600 9,790,600
Credit-Link Notes    
Other borrowings $ 117,196 $ 118,838
[1] Excludes accrued interest receivable of $11.3 million at March 31, 2025 which is recorded in "Other assets" on the condensed consolidated balance sheets
[2] Excludes accrued interest receivable of $13.4 million at December 31, 2024 which is recorded in "Other assets" on the condensed consolidated balance sheets